SCHEMBL23966794

SCHEMBL23966794

N=Cc1cc(OCC2CC2)c(Br)cc1N

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.35
SCN9A Q15858 2/20 0.34
CGAS Q8N884 1/20 0.33
PIM1 P11309 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
HTR2C P28335 7/20 0.32
HTR2B P41595 4/20 0.32
HTR2A P28223 3/20 0.32
AAK1 Q2M2I8 1/20 0.32
POLB P06746 1/20 0.32
DHFR P00374 1/20 0.32
CDK2 P24941 1/20 0.32
RIPK1 Q13546 1/20 0.31
THRA P10827 1/20 0.31
THRB P10828 1/20 0.31
MCHR1 Q99705 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23915570 0.84 CNR2 (0.39) CNR2SCN9AHTR2CHTR2BHTR2A
SCHEMBL16738735 0.78 MCHR1 (0.42) SCN9AHTR2CAAK1CDK2THRA
SCHEMBL16650978 0.71 RIPK1 (0.41) HTR2CHTR2BHTR2ARIPK1MCHR1
SCHEMBL31027311 0.70 SCD (0.42) CNR2SCN9AHTR2CHTR2BHTR2A
SCHEMBL21957402 0.70 SCD (0.42) CNR2SCN9AHTR2CHTR2BHTR2A
SCHEMBL23966847 0.70 AAK1 (0.40) CNR2SCN9AHTR2CHTR2BHTR2A
SCHEMBL5241392 0.69 CNR2 (0.38) CNR2SCN9AHTR2CHTR2B
SCHEMBL23966507 0.68 KDM4E (0.39) HTR2CHTR2BHTR2ACDK2RIPK1
SCHEMBL12891258 0.67 HRH3 (0.39) PIM1PIM2THRATHRB
SCHEMBL15541723 0.67 SLC6A4 (0.42) CNR2SCN9APIM1PIM2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649119-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2021-11-03 EP disclosed